Summary by Moomoo AI
Sai Sing Pharmaceutical Holdings Limited announced on 16 April 2024 that SciClone Option Management Limited, its wholly-owned subsidiary SciClone Option Management Limited, has entered into a share transaction involving the sale of 254,000 shares. The transaction was to satisfy the call options exercised under the Company's Share Option Incentive Scheme at a trading price of HK$1.6562 per share. Following the share sale, SciClone Option Management Limited's stake in Saigon Pharmaceuticals is 2.6023%. The transaction is wholly owned by Maples Trustee Services (Cayman) Limited as the trustee of the Caisson Trust and was completed on 11 April 2024.